Effect of Upper Extremity Support on Spatiotemporal Parameters of Gait in Individuals With Stroke
The Effect of Upper Extremity Support Usage on Spatiotemporal Gait Parameters in Individuals With Stroke: A Prospective Cross-over Experimental Study
1 other identifier
interventional
34
1 country
1
Brief Summary
Purpose: The primary goal of this study is to investigate how different levels of upper extremity (arm) support affect walking patterns in individuals who have experienced a stroke. Specifically, the research aims to determine how restricting or facilitating arm swing during walking modulates spatiotemporal gait parameters (such as speed, step length, and rhythm). Background: Arm swing plays a crucial role in maintaining balance, stability, and energy efficiency during normal walking. Following a stroke, many patients use walking aids (like canes or walkers) or clinical supports (like parallel bars) that restrict natural arm movement. This study examines whether these restrictions significantly alter gait mechanics in the stroke population. Methodology: Participants will participate in a cross-over experimental trial. Each participant will walk on a specialized treadmill system (C-Mill VR+) under three randomized conditions: 1. Unsupported walking (no arm support), 2. Single-arm support (using the non-paretic side), 3. Dual-arm support (using both arms). Researchers will record gait speed, step length, cadence, and duration of stance/swing phases for each condition. Expected Outcome: The findings will provide scientific evidence on how different support strategies modulate walking performance. This information will help physical therapists design more effective, individualized rehabilitation programs to improve mobility and quality of life for stroke survivors.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable stroke
Started Apr 2026
Shorter than P25 for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 11, 2026
CompletedFirst Posted
Study publicly available on registry
March 27, 2026
CompletedStudy Start
First participant enrolled
April 1, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
March 27, 2026
March 1, 2026
9 months
March 11, 2026
March 23, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cadence
Data will be collected using the C-Mill VR+ force-plate integrated treadmill system at a sampling frequency of 500 Hz. These parameters will be used to compare the biomechanical differences between unsupported, single-arm, and dual-arm supported walking.
At the end of each 2-minute walking condition during the single study session.
Stride length
Data will be collected using the C-Mill VR+ force-plate integrated treadmill system at a sampling frequency of 500 Hz. These parameters will be used to compare the biomechanical differences between unsupported, single-arm, and dual-arm supported walking.
At the end of each 2-minute walking condition during the single study session.
Double Support Time
Data will be collected using the C-Mill VR+ force-plate integrated treadmill system at a sampling frequency of 500 Hz. These parameters will be used to compare the biomechanical differences between unsupported, single-arm, and dual-arm supported walking.
At the end of each 2-minute walking condition during the single study session.
Secondary Outcomes (6)
Functional Walking Speed (10-Meter Walk Test)
Baseline (at the beginning of the study session).
Functional Ambulation Category (FAC)
Baseline (at the beginning of the study session).
Hemiplegic Side Step Length
At the end of each 2-minute walking condition during the single study session.
Hemiplegic Stance Time
At the end of each 2-minute walking condition during the single study session.
Non-Hemiplegic Stance Time
At the end of each 2-minute walking condition during the single study session.
- +1 more secondary outcomes
Study Arms (3)
Unsupported Walking
EXPERIMENTALParticipants will walk on the C-Mill VR+ treadmill at their comfortable walking speed without using any upper extremity support or handrails. This condition serves as the baseline for gait spatiotemporal parameters.
Single-Arm Support
EXPERIMENTALParticipants will walk on the C-Mill VR+ treadmill while using only their non-paretic (stronger) upper extremity for support on the handrail. This condition simulates the use of a single-sided walking aid (like a cane or tripod).
Dual-Arm Support
EXPERIMENTALParticipants will walk on the C-Mill VR+ treadmill while using both upper extremities for support on the handrails. This condition represents maximal upper limb support during gait, commonly seen in early rehabilitation or parallel bar training.
Interventions
Description: A treadmill system equipped with integrated force plates and augmented reality (VR) capabilities. It records spatiotemporal gait data at a 500 Hz sampling frequency. In this study, the device is used to measure gait parameters under different upper extremity support conditions.
The standardized protocol of walking under no support: Natural walking with free arm swing. Each trial lasts 2 minutes with mandatory rest periods to prevent fatigue.
The standardized protocol of walking under unilateral support: Holding the handrail with the non-paretic hand. Each trial lasts 2 minutes with mandatory rest periods to prevent fatigue.
The standardized protocol of walking under bilateral support: Holding the handrails with both hands. Each trial lasts 2 minutes with mandatory rest periods to prevent fatigue.
Eligibility Criteria
You may qualify if:
- Diagnosis of hemiplegia with ICD-10 code G.81.
- Presence of unilateral hemiplegia.
- No medical contraindications for the use of assistive devices (e.g., cane, tripod).
- Aged 18 years or older.
- Ability to walk for at least 2 consecutive minutes.
You may not qualify if:
- Presence of aphasia.
- Recurrent stroke.
- Montreal Cognitive Assessment (MoCA) score below 10 points.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ankara Bilkent City Hospital
Ankara, 06800, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
March 11, 2026
First Posted
March 27, 2026
Study Start
April 1, 2026
Primary Completion (Estimated)
December 15, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
March 27, 2026
Record last verified: 2026-03